Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,353,630
+$347,259 QoQ
Shares Held
744,791
-12.5% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,353,630 | 744,791 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,006,371 | 850,744 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,296,128 | 838,144 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,549,218 | 624,650 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,044,114 | 498,848 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,447,177 | 486,869 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,820,124 | 404,978 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,510,429 | 457,953 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,253,535 | 410,337 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,069,792 | 378,416 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,960,426 | 381,865 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $5,076,825 | 398,808 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,693,590 | 417,208 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $6,114,451 | 461,468 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,640,729 | 485,851 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,357,116 | 430,699 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $5,744,530 | 296,875 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,409,306 | 255,612 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,854,428 | 230,666 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,058,351 | 228,065 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,782,246 | 232,824 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,783,435 | 951,044 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,279,025 | 1,749,189 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $16,982,680 | 1,214,784 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,693,261 | 1,249,427 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||